Market Cap 25.91M
Revenue (ttm) 1.41M
Net Income (ttm) -62.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,426.95%
Debt to Equity Ratio -0.93
Volume 2,198,700
Avg Vol 4,244,730
Day's Range N/A - N/A
Shares Out 104.61M
Stochastic %K 52%
Beta 0.32
Analysts Sell
Price Target $5.38

Company Profile

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therap...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 619 3990
Address:
111 S. Wood Avenue, Unit #100, Iselin, United States
DidYouReadThis
DidYouReadThis May. 13 at 12:34 PM
0 · Reply
Autolus_Freakk
Autolus_Freakk May. 13 at 11:27 AM
$OTLK The FDA are doing an audit of recent approvals and refusals I am told by someone who knows someone at the FDA.. (Don't hold me to this information !! )
1 · Reply
LDCap
LDCap May. 13 at 11:24 AM
$OTLK buy and hold, the times are changing.
0 · Reply
janed102
janed102 May. 13 at 6:04 AM
$OTLK https://www.theguardian.com/us-news/2026/may/12/marty-makary-fda-trump-administration
0 · Reply
zerocool00
zerocool00 May. 12 at 10:50 PM
$OTLK FDA commissioner Marty Makary has resigned.
1 · Reply
twib
twib May. 12 at 9:17 PM
$OTLK Sorry to cross post but.. Ck out sls to make up some losses. Its at the very end(78 of 80 deaths)of pz 3 trial. It has two powerful assets in cancer space so not the usual binary bio play. Again sorry to those that hate this. Like to see my old peeps $. Maybe look for some dips, hard to say how nuts tmrw will be.
1 · Reply
GenerallyGentle
GenerallyGentle May. 12 at 7:58 PM
$OTLK buying more tomorrow
0 · Reply
GenerallyGentle
GenerallyGentle May. 12 at 7:52 PM
$OTLK dont let the little red day fool you. higher low today and the sellers failed to put in a lower low. weak selling pressure. nice pivot at .2265 today
1 · Reply
Usually_Im_Right
Usually_Im_Right May. 12 at 6:47 PM
$OTLK .50+ yet?
0 · Reply
eureka
eureka May. 12 at 6:36 PM
$OTLK inflation up stocks down
1 · Reply
Latest News on OTLK
Outlook Therapeutics Announces Proposed Public Offering

Mar 23, 2026, 5:30 PM EDT - 7 weeks ago

Outlook Therapeutics Announces Proposed Public Offering


Outlook Therapeutics sumbits Type A meeting request to FDA

2026-02-11T13:50:19.000Z - 3 months ago

Outlook Therapeutics sumbits Type A meeting request to FDA


Outlook Therapeutics Announces New Employment Inducement Grants

Dec 26, 2025, 5:00 PM EST - 4 months ago

Outlook Therapeutics Announces New Employment Inducement Grants


Outlook Therapeutics Provides Update on Type A Meeting with FDA

Sep 29, 2025, 8:45 AM EDT - 8 months ago

Outlook Therapeutics Provides Update on Type A Meeting with FDA


Outlook Therapeutics Requests Type A Meeting with FDA

Sep 2, 2025, 8:35 AM EDT - 9 months ago

Outlook Therapeutics Requests Type A Meeting with FDA


Outlook Therapeutics Transcript: Status Update

Aug 28, 2025, 8:30 AM EDT - 9 months ago

Outlook Therapeutics Transcript: Status Update


Outlook Therapeutics Transcript: Status Update

Jun 25, 2025, 12:00 PM EDT - 11 months ago

Outlook Therapeutics Transcript: Status Update


Outlook Therapeutics Transcript: Study Update

Feb 3, 2025, 7:00 PM EST - 1 year ago

Outlook Therapeutics Transcript: Study Update


Outlook Therapeutics® Streamlines Operations

Dec 13, 2024, 4:30 PM EST - 1 year ago

Outlook Therapeutics® Streamlines Operations


DidYouReadThis
DidYouReadThis May. 13 at 12:34 PM
0 · Reply
Autolus_Freakk
Autolus_Freakk May. 13 at 11:27 AM
$OTLK The FDA are doing an audit of recent approvals and refusals I am told by someone who knows someone at the FDA.. (Don't hold me to this information !! )
1 · Reply
LDCap
LDCap May. 13 at 11:24 AM
$OTLK buy and hold, the times are changing.
0 · Reply
janed102
janed102 May. 13 at 6:04 AM
$OTLK https://www.theguardian.com/us-news/2026/may/12/marty-makary-fda-trump-administration
0 · Reply
zerocool00
zerocool00 May. 12 at 10:50 PM
$OTLK FDA commissioner Marty Makary has resigned.
1 · Reply
twib
twib May. 12 at 9:17 PM
$OTLK Sorry to cross post but.. Ck out sls to make up some losses. Its at the very end(78 of 80 deaths)of pz 3 trial. It has two powerful assets in cancer space so not the usual binary bio play. Again sorry to those that hate this. Like to see my old peeps $. Maybe look for some dips, hard to say how nuts tmrw will be.
1 · Reply
GenerallyGentle
GenerallyGentle May. 12 at 7:58 PM
$OTLK buying more tomorrow
0 · Reply
GenerallyGentle
GenerallyGentle May. 12 at 7:52 PM
$OTLK dont let the little red day fool you. higher low today and the sellers failed to put in a lower low. weak selling pressure. nice pivot at .2265 today
1 · Reply
Usually_Im_Right
Usually_Im_Right May. 12 at 6:47 PM
$OTLK .50+ yet?
0 · Reply
eureka
eureka May. 12 at 6:36 PM
$OTLK inflation up stocks down
1 · Reply
adayxs
adayxs May. 12 at 6:19 PM
$OTLK The good news I hope is, Diamantas is a streamline guy.
0 · Reply
AnalystLLM
AnalystLLM May. 12 at 6:08 PM
$OTLK fda head out
0 · Reply
GooningToday
GooningToday May. 12 at 5:53 PM
$OTLK the volume pops are dilution lmao
0 · Reply
KoalaFlipper
KoalaFlipper May. 12 at 5:24 PM
$OTLK is it may 14 or may 21 the earnings report come?
3 · Reply
TheMagnificentFerengi
TheMagnificentFerengi May. 12 at 5:24 PM
$EZGO $HAO $OTLK Yes it was exciting watching how far and fast these crashed
1 · Reply
mountainman5050
mountainman5050 May. 12 at 4:48 PM
$OTLK I’m glad I have my trusted safety blanket 👍😆💚
0 · Reply
Alder77
Alder77 May. 12 at 4:42 PM
$OTLK We're going back to the base, with everyone's blessing. I believe the FDA and revenue news will be terrible and will put an end to this company. It will be impossible to avoid bankruptcy and liquidation.
0 · Reply
VoxChameleon
VoxChameleon May. 12 at 4:36 PM
$OTLK brutal
4 · Reply
adayxs
adayxs May. 12 at 3:40 PM
$OTLK I truly hope they did this. Bring reinforcements. Never attend potentially contentious FDA meetings alone—bring experts who know the data, law, and guidance.
1 · Reply
adayxs
adayxs May. 12 at 3:37 PM
$OTLK Dr. Sherman’s advice is firm and simple: “When in doubt, ask.” Some sponsors burn time and goodwill trying to reverse-engineer what they think the FDA wants. That approach is a recipe for delays, additional review cycles, or even regulatory mistrust. “I can’t count the number of times a sponsor made a decision based on what they assumed we wanted. And I’d ask them—Why didn’t you just ask?”
1 · Reply
adayxs
adayxs May. 12 at 3:36 PM
$OTLK Dr. Sherman’s advice is unwavering: smart sponsors move forward, even when the road looks rough. “Don’t wait for perfect conditions because they will never exist. If your package is ready, get it in line.” The bottom line? Set the pace. Be ready. Be early. Be relentless. In this environment, speed isn’t about rushing—it’s about precision timing.
1 · Reply
Alder77
Alder77 May. 12 at 3:15 PM
$OTLK 5 million in volume to go up and only 500k to lose almost everything. Disgusting scam.
0 · Reply